SCHEMBL10104397

SCHEMBL10104397

Cc1cc(N2CCC(N(C)C)C2)c(F)c(C(F)(F)F)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.39
WDR5 P61964 7/20 0.38
HSD11B1 P28845 1/20 0.37
SOS1 Q07889 3/20 0.37
HRH4 Q9H3N8 1/20 0.36
HRH3 Q9Y5N1 1/20 0.36
HTR2A P28223 1/20 0.35
HTR2C P28335 1/20 0.35
HTR2B P41595 1/20 0.35
EML4 Q9HC35 1/20 0.35
ALK Q9UM73 1/20 0.35
PIM1 P11309 1/20 0.35
PIM3 Q86V86 1/20 0.35
PIM2 Q9P1W9 1/20 0.35
CYP11B1 P15538 1/20 0.35
CYP11B2 P19099 1/20 0.35
MAPK8 P45983 1/20 0.34
MAPK10 P53779 1/20 0.34
BTK Q06187 1/20 0.34
MRGPRX2 Q96LB1 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10104334 0.92 SOS1 (0.37) NOTUMWDR5HSD11B1SOS1HTR2A
SCHEMBL10104492 0.88 SOS1 (0.39) NOTUMWDR5HSD11B1SOS1HRH4
SCHEMBL10104493 0.88 SOS1 (0.39) NOTUMWDR5HSD11B1SOS1HRH4
SCHEMBL10104379 0.79 SOS1 (0.37) NOTUMWDR5HSD11B1SOS1HRH4
SCHEMBL10104392 0.76 HTR2A (0.38) NOTUMHTR2AHTR2CHTR2B
SCHEMBL10104401 0.75 HTR2A (0.37) NOTUMHTR2AHTR2CHTR2B
SCHEMBL20374348 0.75 SOS1 (0.37) NOTUMWDR5HSD11B1SOS1HTR2A
SCHEMBL10104391 0.75 ALDH1A1 (0.39) HRH3HTR2AHTR2CHTR2B
SCHEMBL10104326 0.74 ADRB2 (0.44) WDR5HTR2AHTR2CHTR2BPIM1
SCHEMBL14450220 0.73 FPR1 (0.43) WDR5PIM1PIM3PIM2CYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8889665-B2 Chemical compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-11-18 US disclosed
US-8778929-B2 Substituted heteroaryl inhibitors of B-RAF BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-07-15 US disclosed
US-8653087-B2 Pyrido [5, 4-D] pyrimidines as cell proliferation inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-02-18 US disclosed
US-20120094975-A1 PYRIDO [5, 4-D] PYRIMIDINES AS CELL PROLIFERATION INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-04-19 US disclosed
US-20110312939-A1 NEW CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-12-22 US disclosed
US-20110183952-A1 NEW CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-07-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110183952-A1 NEW CHEMICAL COMPOUNDS MKI67, CCNA1, CCNT1 NOTUM 3158/4885WDR5 3533/4885HSD11B1 221/4885
US-20110312939-A1 NEW CHEMICAL COMPOUNDS CCNA1, CCNT1, MKI67 NOTUM 4461/4885WDR5 4258/4885HSD11B1 283/4885
US-20120094975-A1 PYRIDO [5, 4-D] PYRIMIDINES AS CELL PROLIFERATION INHIBITORS CCNT1, CCNA1, CCND1 NOTUM 4803/4885WDR5 2344/4885HSD11B1 3682/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.